Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma

José Antonio López-Guerrero1, Concha López-Ginés, Antonio Pellín

  • 1Department of Pathology, School of Medicine, University of Valencia, Spain.

Insights

Alterations in G1/S checkpoint genes like RB and TP53 are common in osteosarcoma (OS). These genetic changes in OS patients are linked to a poor prognosis, especially in adults.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma (OS) is characterized by complex karyotypes, suggesting the involvement of multiple oncogenes and tumor suppressor genes.
  • The G1 to S-phase checkpoint is crucial for cell cycle regulation and preventing genomic instability.

Purpose of the Study:

  • To investigate molecular alterations in G1 to S-phase checkpoint genes in osteosarcoma pathogenesis.
  • To determine the clinical significance of these alterations in OS patients.

Main Methods:

  • Analysis of RB, TP53, INK4A/ARF locus, CDK4, MDM2, and Cyclin D genes in 29 osteosarcoma samples.
  • Detection of homozygous deletion, methylation, co-amplification, and differential gene expression.
  • Cytogenetic analysis of complex karyotypes, focusing on chromosome losses.

Main Results:

  • Molecular alterations in G1/S checkpoint genes were found in 38% of OS cases.
  • RB and TP53 alterations occurred in 21% and 10% of cases, respectively.
  • INK4A/ARF locus deletions/methylation and CDK4/MDM2 co-amplification were also observed.
  • These genetic alterations were more frequent in adult patients and significantly correlated with a poor prognosis (100% mortality vs. 53% survival).

Conclusions:

  • Deregulation of G1/S checkpoint genes, particularly RB, TP53, and INK4A/ARF, plays a significant role in osteosarcoma development.
  • Identification of these genetic alterations defines a subgroup of osteosarcoma patients with a poor clinical outcome.

Related Concept Videos

The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System02:11

The Cell Cycle Control System

The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...